← Browse by Condition
Medical Condition
thalassemia
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT05736419 Phase 2
Recruiting
A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
Enrollment
24 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
NCT05773729
Recruiting
Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent Beta-thalassemia
Enrollment
10 pts
Location
China
Sponsor
Shanghai BDgene Co., Ltd.